Brands
Discover
Events
Newsletter
More

Follow Us

twitterfacebookinstagramyoutube
Youtstory

Brands

Resources

Stories

General

In-Depth

Announcement

Reports

News

Funding

Startup Sectors

Women in tech

Sportstech

Agritech

E-Commerce

Education

Lifestyle

Entertainment

Art & Culture

Travel & Leisure

Curtain Raiser

Wine and Food

YSTV

ADVERTISEMENT
Advertise with us

4baseCare raises $6M in Series A funding led by Yali Capital

The company plans to enhance product offerings and scale up operations, for further expansion across India, and other countries in Asia and the Middle East.

4baseCare raises $6M in Series A funding led by Yali Capital

Monday August 12, 2024 , 2 min Read

Precision oncology solutions provider 4baseCare has raised $6 million in Series A funding led by Yali Capital and other investors.

The company offers its solutions using advanced genomics and digital health technology.

“4baseCare was founded with an aim to address the critical genomic data gap in cancer care. Our journey from developing TARGT Indiegene to impacting the lives of over 10,000 patients has been a very fulfilling experience,” said Hitesh Goswami, CEO and Co-founder, 4baseCare. 

He further added that this funding will enable them to enhance their product offerings and advance the mission of making personalized cancer care accessible to millions.

The company also plans to scale up operations for further expansion across India, as well as other countries in Asia and the Middle East, it said in a statement.

"The genomics landscape in cancer care offers a tremendous opportunity to create impactful businesses while improving millions of lives. As a deeptech focused fund, we are particularly excited about 4baseCare’s ability to enhance genomic tests with data from underrepresented populations, leading to improved treatment recommendations,” said Mathew Cyriac, Founding General Partner, Yali Capital.

4baseCare plans to set up genomics laboratories in the Philippines, Nepal, and Dubai in the next few months, and will focus on building genomics and digital health solutions, focusing on advanced data analytics, improved clinical insights, and data-driven treatment recommendations, the company said.

The team, which was also selected for Illumina’s accelerator programme in 2019, is supported by an advisory board with leaders in genomics and technology. It also saw the addition of Francis deSouza, a Silicon Valley tech veteran and former CEO of Illumina.

According to the company, its genomic tests have impacted over 10,000 cancer patients across SouthEast Asia.


Edited by Megha Reddy